An overview of generalized anxiety disorder: disease state--appropriate therapy.
about
The behavioral profile of the potent and selective mGlu5 receptor antagonist 3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine (MTEP) in rodent models of anxiety.Generalized anxiety disorder and health care useTest-retest reliability of self-reported age at onset of selected psychiatric diagnoses in general health care.Single use of sumatriptan: a patient interview study.Improvement of psychic and somatic symptoms in adult patients with generalized anxiety disorder: examination from a duloxetine, venlafaxine extended-release and placebo-controlled trial.
P2860
An overview of generalized anxiety disorder: disease state--appropriate therapy.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
An overview of generalized anxiety disorder: disease state--appropriate therapy.
@ast
An overview of generalized anxiety disorder: disease state--appropriate therapy.
@en
type
label
An overview of generalized anxiety disorder: disease state--appropriate therapy.
@ast
An overview of generalized anxiety disorder: disease state--appropriate therapy.
@en
prefLabel
An overview of generalized anxiety disorder: disease state--appropriate therapy.
@ast
An overview of generalized anxiety disorder: disease state--appropriate therapy.
@en
P1476
An overview of generalized anxiety disorder: disease state--appropriate therapy.
@en
P2093
Lydiard RB
P304
A3-19; discussion A20-4
P356
10.1016/S0149-2918(00)89070-0
P478
22 Suppl A
P577
2000-01-01T00:00:00Z